It therefore recommended its continuous use to tame the
pandemic.
“WHO considers that the benefits of the AstraZeneca vaccine
outweigh its risks and recommends that vaccinations continue”, the global
health regulator said.
WHO spoke as some countries in the European Union (EU)
temporarily suspended the use of the AstraZeneca COVID-19 vaccine.
The measure was a precautionary measure, following reports
that it was causing blood clots.
In a statement, the WHO said this decision was based on
reports of rare blood coagulation disorders in persons who had received the
vaccine.
It said, however, that other countries in the EU – having
considered the same information – had decided to continue using the vaccine in
their immunization programmes.
“Vaccination against COVID-19 will not reduce illness or
deaths from other causes. Thromboembolic events are known to occur frequently.
Venous thromboembolism is the third most common cardiovascular disease
globally.
“In extensive vaccination campaigns, it is routine for
countries to signal potential adverse events following immunization.
“This does not necessarily mean that the events are linked
to vaccination itself, but it is good practice to investigate them.
“It also shows that the surveillance system works and that
effective controls are in place, the statement said.
The statement said the WHO was in regular contact with the
European Medicines Agency and regulators around the world for the latest
information on COVID-19 vaccine safety.
“The WHO Global Advisory Committee on Vaccine Safety is
carefully assessing the latest available safety data for the AstraZeneca
vaccine.
“Once that review is completed, WHO will immediately
communicate the findings to the public.
“At this time, WHO considers that the benefits of the AstraZeneca
vaccine outweigh its risks and recommends that vaccinations continue,” the
statement said.
.jpeg)
0 comments:
Post a Comment